Premium
The significance of advisory‐review committees during clinical investigations of drugs
Author(s) -
McCawley Elton L.,
Hart Harold C.,
Crowe Austin W.
Publication year - 1972
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt1972133299
Subject(s) - advisory committee , threatened species , medicine , family medicine , political science , public administration , ecology , habitat , biology
During the two years experience of the advisory‐review committee, members of our staff and the advisory‐review committee were defendants in one civil law suit and have been threatened with two others concerning the right to be given an investigational drug and for the death of one patient. Finally, the Bureau of Narcotics and Dangerous Drugs threatened to terminate the program. The review committee has so far been successful in shielding the investigator and the program continues.